{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:23:28Z","timestamp":1767036208093,"version":"3.48.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Center Climbing Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cervical cancer remains a major global health burden, necessitating the identification of novel therapeutic targets to overcome the limitations of current treatments. Here, we comprehensively investigated the role of integrator complex subunit 13 (INTS13) in cervical cancer progression. Our analysis of publicly available The Cancer Genome Atlas (TCGA) datasets revealed that\n                    <jats:italic>INTS13<\/jats:italic>\n                    is significantly overexpressed in cervical cancer tissues across various histological subtypes, correlating with advanced tumor T-stage and predicting poorer overall survival. Single-cell RNA sequencing further localized INTS13 expression predominantly to malignant epithelial cells within the tumor microenvironment, where its expression correlated with genes involved in critical cellular processes. Furthermore, elevated expression has been observed in cervical cancer tissues from surgically-treated patients and in various primary human cervical cancer cells. In vitro functional studies demonstrated that genetic silencing or CRISPR\/Cas9-mediated knockout of INTS13 significantly inhibited the proliferation, migration, and invasion of primary cervical cancer cells, while selectively inducing apoptosis. Conversely, ectopic INTS13 overexpression markedly enhanced these malignant phenotypes. Mechanistically, we identified heterogeneous nuclear ribonucleoprotein C (hnRNPC) as a critical downstream effector, with INTS13 regulating hnRNPC expression, and the restoration of hnRNPC effectively reversing the anti-cervical cancer effects observed upon INTS13 silencing. Furthermore, the transcription factor ZNF384 (zinc finger protein 384) was identified as an upstream regulator that directly binds to and positively governs INTS13 expression. Finally, in vivo animal models confirmed that targeted silencing of INTS13 significantly impeded cervical cancer xenograft growth in nude mice, reduced cellular proliferation, and augmented apoptosis, consistently accompanied by a reduction in hnRNPC expression. These findings collectively establish INTS13 as a crucial precancerous gene in cervical cancer, promoting malignant phenotypes primarily through the ZNF384-INTS13-hnRNPC signaling axis.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08374-6","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:23:26Z","timestamp":1766420606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8946-9945","authenticated-orcid":false,"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser Perera","family":"Negrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4054-9623","authenticated-orcid":false,"given":"Fang-Rong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2060-9853","authenticated-orcid":false,"given":"Rong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"8374_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393:169\u201382.","journal-title":"Lancet"},{"key":"8374_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"8374_CR3","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"8374_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30244","volume":"10","author":"B Wang","year":"2024","unstructured":"Wang B, Du Z, Lin C, Liu D, Guo J, Shi J, et al. Comprehensive analysis of INTS family related to expression, prognosis, diagnosis and immune features in hepatocellular carcinoma. Heliyon. 2024;10:e30244.","journal-title":"Heliyon"},{"key":"8374_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33547-8","volume":"13","author":"LG Mascibroda","year":"2022","unstructured":"Mascibroda LG, Shboul M, Elrod ND, Colleaux L, Hamamy H, Huang KL, et al. INTS13 variants causing a recessive developmental ciliopathy disrupt assembly of the Integrator complex. Nat Commun. 2022;13:6054.","journal-title":"Nat Commun"},{"key":"8374_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.currproblcancer.2018.06.003","volume":"42","author":"M Vu","year":"2018","unstructured":"Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer. 2018;42:457\u201365.","journal-title":"Curr Probl Cancer"},{"key":"8374_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1155\/2007\/914823","volume":"23","author":"FX Bosch","year":"2007","unstructured":"Bosch FX, de Sanjose S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers. 2007;23:213\u201327.","journal-title":"Dis Markers"},{"key":"8374_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395:575\u201390.","journal-title":"Lancet"},{"key":"8374_CR9","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1080\/15384101.2016.1191257","volume":"15","author":"G Trave","year":"2016","unstructured":"Trave G, Zanier K. HPV-mediated inactivation of tumor suppressor p53. Cell Cycle. 2016;15:2231\u20132.","journal-title":"Cell Cycle"},{"key":"8374_CR10","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1038\/sj.onc.1202953","volume":"18","author":"M Thomas","year":"1999","unstructured":"Thomas M, Pim D, Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. 1999;18:7690\u2013700.","journal-title":"Oncogene"},{"key":"8374_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104721","volume":"211","author":"V Ranasinghe","year":"2025","unstructured":"Ranasinghe V, McMillan N. Novel therapeutic strategies for targeting E6 and E7 oncoproteins in cervical cancer. Crit Rev Oncol Hematol. 2025;211:104721.","journal-title":"Crit Rev Oncol Hematol"},{"key":"8374_CR12","doi-asserted-by":"publisher","first-page":"12782","DOI":"10.1016\/S0021-9258(19)38226-2","volume":"265","author":"RE Jones","year":"1990","unstructured":"Jones RE, Wegrzyn RJ, Patrick DR, Balishin NL, Vuocolo GA, Riemen MW, et al. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. J Biol Chem. 1990;265:12782\u20135.","journal-title":"J Biol Chem"},{"key":"8374_CR13","volume":"39","author":"SK Ong","year":"2023","unstructured":"Ong SK, Abe SK, Thilagaratnam S, Haruyama R, Pathak R, Jayasekara H, et al. Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. Lancet Reg Health West Pac. 2023;39:100860.","journal-title":"Lancet Reg Health West Pac"},{"key":"8374_CR14","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","volume":"10","author":"L Bruni","year":"2022","unstructured":"Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022;10:e1115\u2013e1127.","journal-title":"Lancet Glob Health"},{"key":"8374_CR15","first-page":"242s","volume":"12","author":"EI Garner","year":"2003","unstructured":"Garner EI. Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev. 2003;12:242s\u20137s.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8374_CR16","unstructured":"Chemoradiotherapy for cervical cancer meta-analysis. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst Rev. 2010;1:CD008285."},{"key":"8374_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41571-024-00977-w","volume":"22","author":"AA Francoeur","year":"2025","unstructured":"Francoeur AA, Monk BJ, Tewari KS. Treatment advances across the cervical cancer spectrum. Nat Rev Clin Oncol. 2025;22:182\u201399.","journal-title":"Nat Rev Clin Oncol"},{"key":"8374_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000462","volume":"3","author":"C Vora","year":"2018","unstructured":"Vora C, Gupta S. Targeted therapy in cervical cancer. ESMO Open. 2018;3:e000462.","journal-title":"ESMO Open"},{"key":"8374_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2147\/IJWH.S49471","volume":"6","author":"A Duenas-Gonzalez","year":"2014","unstructured":"Duenas-Gonzalez A, Serrano-Olvera A, Cetina L, Coronel J. New molecular targets against cervical cancer. Int J Womens Health. 2014;6:1023\u201331.","journal-title":"Int J Womens Health"},{"key":"8374_CR20","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.molcel.2024.05.009","volume":"84","author":"M Razew","year":"2024","unstructured":"Razew M, Fraudeau A, Pfleiderer MM, Linares R, Galej WP. Structural basis of the Integrator complex assembly and association with transcription factors. Mol Cell. 2024;84:2542\u201352e2545.","journal-title":"Mol Cell"},{"key":"8374_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-024-07269-4","volume":"629","author":"I Fianu","year":"2024","unstructured":"Fianu I, Ochmann M, Walshe JL, Dybkov O, Cruz JN, Urlaub H, et al. Structural basis of Integrator-dependent RNA polymerase II termination. Nature. 2024;629:219\u201327.","journal-title":"Nature"},{"key":"8374_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17232-2","volume":"11","author":"K Sabath","year":"2020","unstructured":"Sabath K, Staubli ML, Marti S, Leitner A, Moes M, Jonas S. INTS10-INTS13-INTS14 form a functional module of Integrator that binds nucleic acids and the cleavage module. Nat Commun. 2020;11:3422.","journal-title":"Nat Commun"},{"key":"8374_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-022-00534-2","volume":"24","author":"SA Welsh","year":"2023","unstructured":"Welsh SA, Gardini A. Genomic regulation of transcription and RNA processing by the multitasking Integrator complex. Nat Rev Mol Cell Biol. 2023;24:204\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8374_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.tibs.2020.07.004","volume":"45","author":"MS Mendoza-Figueroa","year":"2020","unstructured":"Mendoza-Figueroa MS, Tatomer DC, Wilusz JE. The integrator complex in transcription and development. Trends Biochem Sci. 2020;45:923\u201334.","journal-title":"Trends Biochem Sci"},{"key":"8374_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07768-w","volume":"16","author":"P Li","year":"2025","unstructured":"Li P, Chen J, Wang J, Liu T. Gap junction protein beta 5 interacts with Galphai3 to promote Akt activation and cervical cancer cell growth. Cell Death Dis. 2025;16:461.","journal-title":"Cell Death Dis"},{"key":"8374_CR26","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.7150\/ijbs.77126","volume":"18","author":"J Zhang","year":"2022","unstructured":"Zhang J, Yin DP, Zhang Y, Zhang JN, Yang Y, Zhang ZQ, et al. Identification of Galphai3 as a novel molecular therapeutic target of cervical cancer. Int J Biol Sci. 2022;18:5667\u201380.","journal-title":"Int J Biol Sci"},{"key":"8374_CR27","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s42003-022-04142-w","volume":"5","author":"C Li","year":"2022","unstructured":"Li C, Wu H, Guo L, Liu D, Yang S, Li S, et al. Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer. Commun Biol. 2022;5:1208.","journal-title":"Commun Biol"},{"key":"8374_CR28","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.7150\/thno.55655","volume":"11","author":"YY Gao","year":"2021","unstructured":"Gao YY, Ling ZY, Zhu YR, Shi C, Wang Y, Zhang XY, et al. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma. Theranostics. 2021;11:4599\u2013615.","journal-title":"Theranostics"},{"key":"8374_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06308-8","volume":"14","author":"DP Yin","year":"2023","unstructured":"Yin DP, Zhang H, Teng H, Zhang D, Chen P, Xie L, et al. Overexpressed Galphai1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma. Cell Death Dis. 2023;14:792.","journal-title":"Cell Death Dis"},{"key":"8374_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.32604\/or.2024.055866","volume":"33","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang Z, Dong J, Liu C. HNRNPC as a pan-cancer biomarker and therapeutic target involved in tumor progression and immune regulation. Oncol Res. 2025;33:83\u2013102.","journal-title":"Oncol Res"},{"key":"8374_CR31","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/ijms18050936","volume":"18","author":"A Federico","year":"2017","unstructured":"Federico A, Rienzo M, Abbondanza C, Costa V, Ciccodicola A, Casamassimi A. Pan-cancer mutational and transcriptional analysis of the integrator complex. Int J Mol Sci. 2017;18:936.","journal-title":"Int J Mol Sci"},{"key":"8374_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0955-0674(99)80051-9","volume":"11","author":"AM Krecic","year":"1999","unstructured":"Krecic AM, Swanson MS. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol. 1999;11:363\u201371.","journal-title":"Curr Opin Cell Biol"},{"key":"8374_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00366-4","volume":"10","author":"L Mo","year":"2022","unstructured":"Mo L, Meng L, Huang Z, Yi L, Yang N, Li G. An analysis of the role of HnRNP C dysregulation in cancers. Biomark Res. 2022;10:19.","journal-title":"Biomark Res"},{"key":"8374_CR34","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.2147\/CMAR.S330713","volume":"13","author":"S Wang","year":"2021","unstructured":"Wang S, Xu G, Chao F, Zhang C, Han D, Chen G. HNRNPC promotes proliferation, metastasis and predicts prognosis in prostate cancer. Cancer Manag Res. 2021;13:7263\u201376.","journal-title":"Cancer Manag Res"},{"key":"8374_CR35","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1111\/jcmm.17254","volume":"26","author":"N Xia","year":"2022","unstructured":"Xia N, Yang N, Shan Q, Wang Z, Liu X, Chen Y, et al. HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer. J Cell Mol Med. 2022;26:2322\u201336.","journal-title":"J Cell Mol Med"},{"key":"8374_CR36","doi-asserted-by":"publisher","first-page":"7580","DOI":"10.1093\/nar\/gkz461","volume":"47","author":"H Fischl","year":"2019","unstructured":"Fischl H, Neve J, Wang Z, Patel R, Louey A, Tian B, et al. hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles. Nucleic Acids Res. 2019;47:7580\u201391.","journal-title":"Nucleic Acids Res"},{"key":"8374_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07108-4","volume":"15","author":"YY Liu","year":"2024","unstructured":"Liu YY, Xia M, Chen ZB, Liao YD, Zhang CY, Yuan L, et al. HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1. Cell Death Dis. 2024;15:732.","journal-title":"Cell Death Dis"},{"key":"8374_CR38","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/sj.leu.2405084","volume":"22","author":"CH Zhong","year":"2008","unstructured":"Zhong CH, Prima V, Liang X, Frye C, McGavran L, Meltesen L, et al. E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia. Leukemia. 2008;22:723\u20139.","journal-title":"Leukemia"},{"key":"8374_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s10020-022-00541-1","volume":"28","author":"QX Meng","year":"2022","unstructured":"Meng QX, Wang KN, Li JH, Zhang H, Chen ZH, Zhou XJ, et al. ZNF384-ZEB1 feedback loop regulates breast cancer metastasis. Mol Med. 2022;28:111.","journal-title":"Mol Med"},{"key":"8374_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/or.2022.8260","volume":"47","author":"Z Yan","year":"2022","unstructured":"Yan Z, Zhou Y, Yang Y, Zeng C, Li P, Tian H, et al. Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP2. Oncol Rep. 2022;47:49.","journal-title":"Oncol Rep"},{"key":"8374_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbrc.2015.03.068","volume":"460","author":"S Mori","year":"2015","unstructured":"Mori S, Takeuchi T, Ishii Y, Kukimoto I. Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6. Biochem Biophys Res Commun. 2015;460:555\u201360.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08374-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:20:16Z","timestamp":1767036016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08374-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8374"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08374-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"type":"electronic","value":"2041-4889"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"920"}}